Ireland
--:--IST
Latest
Budget 2027: €29.1bn for Health, Rare Disease Medicines Pilot Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Budget 2027: €29.1bn for Health, Rare Disease Medicines Pilot Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity
Clinical Trials in Italy / NCT06824623
Recruiting Observational

Readmission and Dehydration Prevention in Patients With Elective Ileostomy

NCT06824623 · tracked via the Priya Life Science Italy tracker
Sponsor
Multidisciplinary Italian Study group for STOmas (MISSTO)
Phase
Observational
Started
2025-06-01
Last updated
2025-06-11

Condition(s) studied

Ileostomy - StomaColorectal SurgeryDehydration

Study summary

The goal of this prospective observational study is to evaluate the adherence to DRIP score calculation and the application rate of each proposed item to prevent dehydration and readmission in patients undergoing ileostomy creation after elective colorectal resection different Italian colorectal surgical centers.

The primary endpoint is to verifythe application rate of DRIP score calculation and protocol items.

Secondary endpoints are 30, 90, and 180-day total and dehydration readmission rates.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All patients with elective ileostomy performed during the study period for benign or malignant colorectal disease * Age \> 18 years * Written consent Exclusion Criteria: * Emergency surgery * Other ostomy than ileostomy

Primary outcome measure(s)

  • DRIP score calculation and protocol items — From enrollment to the end of recruitment at 6 months
    Application rate of DRIP score calculation and protocol items

Trial sites (7)

FacilityCityRegionStatus
ASST Ovest Milanese, Ospedale di Legnano Legnano Italy Recruiting
Luigi Sacco University Hospital Milan Italy Recruiting
Università degli Studi Milano-Bicocca, Ospedale San Gerardo Monza Italy Recruiting
University of Palermo, "Paolo Giaccone" University Hospital Palermo Italy Recruiting
Ospedale Santa Maria della Misericordia Rovigo Italy Recruiting
ASST Nord Milano, Ospedale Città di Sesto San Giovanni Sesto San Giovanni Italy Recruiting
IRCCS Policlinico di Bologna Bologna Italy Recruiting

Other trials for the same condition

Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY) Recruiting
Nutritional Supplementation to Improve Colorectal Cancer Surgery Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06824623 on ClinicalTrials.gov ↗ ← All trials in Italy